Viewing Study NCT00004223

Bugs

Ignite Creation Date: 2025-12-18 @ 8:16 AM

Ignite Modification Date: 2025-12-23 @ 11:09 PM

Study NCT ID: NCT00004223

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module References Module